Evidence map›Paper›PMID 42369963›Full record

ArticleFrontiers in molecular biosciences2026

Venom gland transcriptomics and bioactivity profiling suggest bifunctional hyaluronidase activity in the venom of

Masoumeh Baradaran, Fatemeh Salabi, Nasrin Payab, Seyed Mahdi Kazemi, Carlos E Santibáñez-López, Tim Lüddecke

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoumeh BaradaranToxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Fatemeh SalabiRazi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Ahvaz, Iran.
Nasrin PayabGraduate of the Department of Biology, Faculty of Science, Shahrekord University, Shahrekord, Iran.
Seyed Mahdi KazemiZagros Herpetological Institute, Qom, Iran.
Carlos E Santibáñez-LópezDepartment of Biology, Western Connecticut State University, Danbury, CT, United States.
Tim LüddeckeFraunhofer Institute for Molecular Biology and Applied Ecology, Gießen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Scorpion venom is a rich source of bioactive molecules with promising biomedical applications. Hyaluronidases are venom-associated enzymes that facilitate toxin diffusion by degrading extracellular matrix glycosaminoglycans, yet their structural diversity and substrate specificity in scorpion venoms remain insufficiently explored. This study aimed to identify and characterize a novel hyaluronidase from the venom gland of the Iranian endemic scorpion Methods: Venom gland transcriptome profiling was performed. Hyaluronidase sequences were analyzed Results: Transcriptomic analysis revealed a diverse toxin repertoire dominated by ion channel modulators and enzymatic components, including a novel precursor encoding a putative hyaluronidase exhibiting a unique cysteine framework with six disulfide bonds and three conserved diagnostic motifs (GDWW, FPDC, and GWGS). Structural modeling suggested catalytic and binding domains consistent with glycosyl hydrolase family 56 enzymes. Molecular docking supported preferential binding affinity toward hyaluronic acid tetrasaccharides rather than longer or highly sulfated glycosaminoglycans. Functional assays on crude venom confirmed strong hyaluronan degradation and slower chondroitin sulfate hydrolysis, indicating dual substrate activity. Discussion: This study supports the existence of a structurally distinct scorpion venom hyaluronidase with putative bifunctional substrate activity. These findings expand current understanding of scorpion venom enzyme evolution and highlight the enzyme's translational potential.

Indexed as

drug discoveryhyaluronidaseMesobuthus crucittiiscorpion venom glandtranscriptomic analysis

Identifiers

PMID42369963
PMCPMC13294633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.